| Pharmacogenomic approaches to asthma treatment. | |
| | |
MedLine Citation:
|
PMID: 20592916 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Major classes of medication in asthma management include bronchodilating beta2-agonists, anti-inflammatory inhaled corticosteroids, leukotriene modifiers and theophyllines. However, all asthmatics do not respond to the same extent to a given medication. Available data suggest that a substantial range of individual variability, as much as 70%, may be due to genetic characteristics of each patient. Pharmacogenomics offers the potential to optimize medications for individual asthmatics by using genetic information to improve efficacy or avoid adverse effects. The best-studied case of the potential contribution of pharmacogenomics to treatment response in asthma comes from studies on human beta2 adrenergic receptors. In addition, genetic variation in beta2-adrenergic receptor (Arg16Gly) may predict response to anticholinergics for the treatment of asthma. In case of inhaled corticosteroids, a recent investigation using a traditional SNP-based approach identified a gene for corticotropin releasing hormone receptor 1 as a potential marker of response. Another major pathway that has been investigated is the pathway underlying response to cysteinyl leukotriene receptor antagonist. It is likely that in the near future, pharmacogenomic approaches based on individual genetic information will be introduced into an asthma treatment guideline and this guideline will allow us to identify those who have the best chance to respond to a specific medication. |
| | |
Authors:
|
Sang-Heon Cho |
Related Documents
:
|
8104076 - Advances in respiratory therapeutics in children. 15479606 - Psoriasis remission after laparoscopic roux-en-y gastric bypass for morbid obesity. 15644146 - The impact of diabetes mellitus and other chronic medical conditions on health-related ... 9480996 - Medications used by children with asthma living in the inner city. 16362716 - Warfarin as a therapeutic option in the control of chronic cluster headache: a report o... 15565196 - Mandatory physician reporting of drivers with cardiac disease: ethical and practical co... |
Publication Detail:
|
Type: Journal Article Date: 2010-05-19 |
Journal Detail:
|
Title: Allergy, asthma & immunology research Volume: 2 ISSN: 2092-7363 ISO Abbreviation: Allergy Asthma Immunol Res Publication Date: 2010 Jul |
Date Detail:
|
Created Date: 2010-07-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101518382 Medline TA: Allergy Asthma Immunol Res Country: Korea (South) |
Other Details:
|
Languages: eng Pagination: 177-82 Citation Subset: - |
Affiliation:
|
Division of Asthma, Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evolution of asthma concept and effect of current asthma management guidelines.
Next Document: The role of oxidative stress in the pathogenesis of asthma.